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Abstract
Background: The prevalence of tobacco usage in Native American adults and adolescents is
higher than any other racial or ethnic group, yet biological risk and protective factors underlying
tobacco use in this ethnic group remain unknown. A genome scan for loci associated with tobacco
use phenotypes was performed with data collected from a community sample of Mission Indians
residing in Southwest California.
Methods: A structured diagnostic interview was used to define two tobacco use phenotypes: 1)
any regular tobacco usage (smoked daily for one month or more) and 2) persistent tobacco usage
(smoked at least 10 cigarettes a day for more than one year). Heritability was determined and a
linkage analysis was performed, using genotypes for a panel 791 microsatellite polymorphisms, for
the two phenotypes using variance component methods implemented in SOLAR.
Results:  Analyses of multipoint variance component LOD scores for the two tobacco use
phenotypes revealed two scores that exceeded 2.0 for the regular use phenotype: one on
chromosomes 6 and one on 8. Four other loci on chromosomes 1,7,13, and 22 were found with
LOD scores between 1.0 and 1.5. Two loci of interest were found on chromosomes 1 and 4 for
the persistent use phenotype with LOD scores between 1.3–1.5. Bivariate linkage analysis was
conducted at the site on chromosome 4 for persistent tobacco use and an alcohol drinking severity
phenotype previously identified at this site. The maximum LOD score for the bivariate analysis for
the region was 3.4, however, there was insufficient power to exclude coincident linkage.
Conclusion: While not providing evidence for linkage to specific chromosomal regions these
results identify regions of interest in the genome in this Mission Indian population, for tobacco
usage, some of which were identified in previous genome scans of non-native populations.
Additionally, these data lend support for the hypothesis that cigarette smoking, alcohol dependence
and other consumptive behaviors may share some common risk and/or protective factors in this
Mission Indian population.
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Background
Tobacco use by North American Indians was documented
by the first European explorers to the continent who
described it as being consumed by smoking, chewing or in
salves [1,2]. Early Indian tobacco usage appeared to be
primarily for ceremonial purposes, and it has been sug-
gested that older forms of tobacco were more potent and
may have contained other psychoactive substances [3].
Currently, smoking rates among North American Indians
are higher than any other racial or ethnic group, despite
significant variation across tribes and regions of Canada
and the US [4-8].
Smoking has been described as particularly prevalent in
Native American youth. No differences have been found
between rural and urban Native American adolescents in
one study of smoking prevalence, and in that study Native
American youth reported more exposure to peers who
smoked and greater access to cigarettes than other racial
and ethnic groups [9]. American Indian middle school
students report initiating smoking with family, friends
and/or peers and also report no links between the initia-
tion of recreational smoking and the use of tobacco in tra-
ditional ceremonies [10].
Psychosocial variables such as death, loss, and other
stressful life events have been demonstrated to be risk fac-
tors for American Indian adolescents initiating smoking
[11], however, such variables do not account for all of the
variance associated with increased risk in this ethnic
group. Studies of smoking behavior in non-native popu-
lations have revealed that smoking-related traits are com-
plex and that genetic variables significantly influence
smoking behaviors [12-14]. There also appears to be some
shared use liability between tobacco and others drugs [15-
18]. Several studies have identified regions in the genome
that are associated with tobacco related phenotypes [19-
26]. Most of the studies have published on one of four
population cohorts: the Collaborative Study on the
Genetics of Alcoholism, the Christchurch New Zealand
sample, a family study of panic disorder, and the Framing-
ham Heart Study. The phenotypes in these studies have
varied and the linkage analyses have not appreciably con-
verged on any single genetic loci. No linkage analyses
have as yet been published in a North American Indian
population. American Indians are a unique population to
study tobacco use phenotypes because of the presumption
of relative genetic homogeneity and possibly more uni-
form exposure to environmental factors that could
improve power in linkage analyses.
The present report is part of a larger study exploring risk
factors for substance dependence among Native American
Mission Indians [27-34]. The lifetime prevalence of alco-
hol and illicit drug dependence in this Indian population
is high, and evidence for heritability of substance depend-
ence has been demonstrated [31,35]. The purpose of the
present set of analyses was to determine the heritability of
tobacco use phenotypes in Mission Indian families and to
identify genetic loci associated with those phenotypes.
These data are also discussed in the context of previously
published genome scans for tobacco use phenotypes in
non-Indian populations as well as data demonstrating
linkage to alcohol use disorder phenotypes in this popu-
lation of Mission Indians [31,36].
Methods
Participants, known collectively as Mission Indians, were
recruited using a combination of a venue-based method
[37,38] and a respondent-driven procedure [39] from
eight geographically contiguous reservations in Southwest
California as described previously [30,31]. Approval for
the study was obtained from both The Scripps Research
Institute Internal Review Board, and The Indian Health
Council Board. Potential participants first met individu-
ally with research staff to have the study explained, give
written informed consent, and respond to a screening
questionnaire that was used to gather information on
demographics, personal medical history, ethnicity and
detailed measures of substance abuse history [40]. Each
participant also completed an interview with the Semi-
Structured Assessment for the Genetics of Alcoholism
(SSAGA) [41] which was used to make drug dependence
diagnoses [42]. The SSAGA is a fully structured, poly-diag-
nostic psychiatric interview that has undergone both reli-
ability and validity testing [41,43]. It has been successfully
used in Native American populations previously [44,45].
The interview retrospectively asks about the initial and
regular use and problems associated with the use of drugs.
The SSAGA I interview also allows for the diagnoses of
drug abuse and dependence, but not for tobacco. There-
fore, two tobacco use phenotypes were constructed based
on individual SSAGA items. The first was regular tobacco
use defined as: smoking daily for a month or more; and
the second was persistent smoking defined as: smoking 10
or more cigarettes a day for more than a year.
One hundred pedigrees containing 885 individuals were
used in the analyses. Of these, 244 individuals have both
genotype and phenotype data and 222 additional individ-
uals have only phenotypic data (total of 466). Fifty-nine
families have only a single individual with phenotype
data. These individuals were included within some analy-
ses to the extent that they contribute information about
trait means and variance and the impact of co-variants.
The family sizes for the remaining families ranged
between 4 and 38 subjects (average 13.5 ± 10) with
between 2 and 15 individuals having both genotype and
phenotype data (average 5.4 ± 4.2). Forty-one families
were genetically informative. The data includes: 77 par-BMC Medical Genetics 2006, 7:9 http://www.biomedcentral.com/1471-2350/7/9
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ent-child, 212 sibling, 26 half sibling, 8 grandparent-
grandchild, 151 avuncular, and 245 cousin relative pairs
where both genotype and phenotype data were available
for both pair members. These data analyses have been
described previously [31,36].
DNA was isolated from whole blood using an automated
DNA extraction procedure, genotyping was done as previ-
ously described [46]. Genotypes were determined for a
panel 791 autosomal microsatellite polymorphisms [47]
using fluorescently labeled PCR primers under conditions
recommended by the manufacturer (HD5 version 2.0;
Applied Biosystems). The HD5 panel set has an average
marker-to-marker distance of 4.6 cM, and an average het-
erozygosity of greater than 77% in a Caucasian popula-
tion. Allele frequencies were estimated from genotype
data for the entire population.
Genotypes were ultimately determined for 243 subjects.
The total additive genetic heritability (H2) and its stand-
ard error were estimated for the regular and persistent
tobacco use phenotypes using SOLAR. Variance compo-
nent estimate methods were used to calculate LOD scores
using SOLAR v2.0.4 [48,49] Genhunter 2 [50] and Merlin
[51] with similar results. Simulation analysis was used to
estimate empirical LOD scores and make appropriate
genome wide adjustments for non-normality when the
trait was modeled as normally distributed trait [52]. Gen-
der was not a significant covariate for either phenotype.
Age accounted for 1% of the phenotypic variance for per-
sistent tobacco usage. Linkage analysis results were not
significantly affected by exclusion of age as a covariate.
Two variance component analytic approaches were used
for the traits. In the first approach the trait was modeled
as a latent normally distributed variable with a threshold
above which an individual is considered "affected". Using
a second approach, the trait was modeled as a normally
distributed variable with a correction for non-normality
based on simulation. For these traits the LOD score was
higher throughout the genome for the latent threshold
model. The figures show the slightly lower LOD analysis
treating the traits as continuous variable with simulations
to correct for normality. These methods can occasionally
give very dissimilar results presumably because of factors
related to convergence. In this analysis it was required that
both methodologies provide support for linkage. All
results presented were derived from the use of SOLAR.
Bivariate analyses were conducted with data on chromo-
some 4 for persistent tobacco use where a loci was identi-
fied in a location at @102 cM where we had previously
identified a linkage signal for alcohol drinking severity
[31]. Drinking severity was defined using items in the
SSAGA. Briefly, the SSAGA groups individual interview
response items into nine categories that correspond to the
nine DSMIII-R criteria used for making an alcohol
dependence diagnosis. These items include: alcohol use
severity items, legal, family, work and medical problems,
tolerance, wanting/unable to quit and withdrawal. Of
these potential phenotypes, alcohol use severity and alco-
hol withdrawal were found to be highly heritable. The
alcohol severity phenotype grouped responses on four
alcohol use severity items: 1) drank more than intended/
more days in a row or when promised self wouldn't for
three or more times, 2) drunk when didn't want to three
or more times, 3) during drinking or recovering from the
effects of drinking had little time for anything else, and 4)
given up or greatly reduced important activities to drink.
Each subject was scored as having 0–4 alcohol severity
symptoms. The bivariate analysis using the persistent
smoking phenotype and the alcohol use severity pheno-
type was performed using SOLAR (2.1.4)[49]. To test for
pleiotropy, by excluding coincident linkage, the method
proposed by Almasy [53] and as elaborated by North [54],
was used. Briefly, the likelihood for the linkage model in
which pq was estimated was compared to the likelihood
for the linkage model in which pq was constrained to 1 (or
Table 1: Chromosome Locations
CHR Trait LOC (cM) LOD Nearest Marker Supporting References (phenotype)
1 Persistent Tob Use 75 1.3 D1S2652
1 Regular Tob Use 175 1.2 D1S196 Bierut et al. 2004 (Alc dep & smoking)
4 Persistent Tob Use 100 1.5 D4S2460 Straub et al. 1999, Duggirala et al. 1999 (Tob), Long et al. 1998 (Alc dep), Reich 
et al. 1998 (Alc dep), Saccone et al. 2003 (Max drinks), Ehlers et al. 2004b(Alc 
drink severity)
6 Regular Tob Use 50–75 2.0 D6S1575 Ehlers et al. 2004b (Alc withdrawal), Bergen et al. 1999 (Smoking)
7 Regular Tob Use 140 1.5 D7S640 Gelernter et al. 2004
8 Regular Tob Use 110 2.0 D8S1762
13 Regular Tob Use 20 1.3 D13S289 Saccone et al. (2003)
22 Regular Tob Use 40–50 1.3 D22S274 Saccone et al. (2003)
Abbreviations: CHR (chromosome number), LOC (location), Tob Use (tobacco usage), Alc dep (Alcohol dependence), Tob (Tobacco use 
phenotypes), Max drinks (maximum number of drinks consumed in a 24 hr period), Alc withdrawal (alcohol withdrawal severity phenotype) Alc 
drink severity (severity of drinking symptoms from DSM-III-R alcohol dependence).BMC Medical Genetics 2006, 7:9 http://www.biomedcentral.com/1471-2350/7/9
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-1 complete pleiotropy) or 0 (complete coincident link-
age).
Results
The demographic characteristics of the sample are virtu-
ally equivalent to the U.S. census data for the tribe, and
have been presented previously [31]. Participants in the
study were between 18 and 60 yrs with a mean age of 30
yrs (0.54), 58% were female, they had a mean education
level of 11 (0.12) yrs and their income was $27,000
(0.11). The number of individuals with a Native American
heritage of greater than 50% was 53% in the larger sample
and 55% in the linkage sample. Indian heritage was based
on their federal Indian blood quantum. The self-reported
racial/ethnic admixture was primarily: Hispanic, Spanish,
and other European. The linkage sample did not differ
from the larger sample on any demographic or pheno-
typic variables.
Two hundred seventy-one out of a larger sample of 466
participants (58%) met the criteria for regular tobacco
usage and (30%) met criteria for persistent usage. Men
were not significantly more likely to be regular users or
persistent users. Nor were those participants having a
native heritage of 50% or greater likely to be regular or
persistent users compared to those with lesser degrees of
Native heritage. The mean age of onset of regular use was
17 yrs and the mean quantity and frequency of usage was
12 cigarettes a day for 9 years. Persistent and regular
smokers did not differ from each other or non-smokers on
age, education or income. The prevalence of alcohol
dependence in the larger sample was 60% and in the link-
age sample it was 61%. Alcohol dependence was co-mor-
bid with both the persistent (Chi square = 12.67; df = 1; p
< 0.0001) and regular (Chi square = 22.60; df = 1; p <
0.00001) smoking phenotypes.
The first aim of the study was to determine the heritability
of the two tobacco phenotypes. The estimated heritability
(h2) for the regular tobacco usage, treating the phenotype
as a continuous variable, was 0.37 ± 0.11 and persistent
tobacco usage, 0.34 ± 0.12. Estimated heritability nomi-
nally increased to 0.53 ± 0.17 and 0.46 ± 0.18 when a
latent threshold model was used.
The second aim of the study was to identify loci linked
with the two tobacco use phenotypes. As seen in Figure 1
and table 1, loci associated with regular tobacco usage
were found on chromosome 6 at 75 cM (between D6S257
and D6S460, LOD = 2.0) and on chromosome 8 at 115
cM (at D8S1784, LOD = 2.0). Additional "loci of interest"
were found on chromosomes 1 at 175 cM (at D1S2878,
LOD = 1.2) chromosome 7 at 181 cM (at D7S2465, LOD
= 1.7) chromosome 13 at 15 cM (D13S217 LOD = 1.3)
and chromosome 22 at 45 cM (between D22S423 and
D22S274, LOD = 1.3). As seen in figure 2 and table 1, only
two "loci of interest" were found for the persistent tobacco
use phenotype, one on chromosome 1 at 40 cm (near
D1S199, LOD = 1.3) and one on chromosome 4 at 102
cM (near D4S414, LOD = 1.5). No overlaps were found
between loci identified for the regular use phenotype and
those found for the persistent use phenotype.
Multipoint Linkage Analysis for the "persistent tobacco use"  phenotype for the entire genome Figure 2
Multipoint Linkage Analysis for the "persistent tobacco use" 
phenotype for the entire genome. Results for each chromo-
some are aligned end to end with the p terminus on the left. 
Vertical lines indicate the boundaries between the chromo-
somes. The numbers above on the X-axis indicate the chro-
mosome number.
Multipoint Linkage Analysis for the "regular tobacco use"  phenotype for the entire genome Figure 1
Multipoint Linkage Analysis for the "regular tobacco use" 
phenotype for the entire genome. Results for each chromo-
some are aligned end to end with the p terminus on the left. 
Vertical lines indicate the boundaries between the chromo-
somes. The numbers above on the X-axis indicate the chro-
mosome number.BMC Medical Genetics 2006, 7:9 http://www.biomedcentral.com/1471-2350/7/9
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The peak LOD score observed for persistent tobacco use at
102 cM on chromosome 4 coincides with LOD score peak
previously reported in this Mission Indian sample for a
drinking severity phenotype [31] (LOD score 2.9). The
region near 100 cM where the peak LOD score was
observed is notable because it contains a cluster of genes
that code for alcohol dehydrogenases (ADH) and has
been implicated in several studies of alcohol and tobacco
use. Table 1 lists the loci identified in the current study
and also provides reference to findings from previously
published studies in this Mission Indian population and
other population samples. In order to test whether the
current findings for drinking severity and persistent smok-
ing are coincident on chromosome 4, bivariate linkage
analysis was conducted (see Figure 3). The maximum
LOD score for the bivariate analysis for the region is 3.4
compared to a maximum of 2.8 for drinking severity score
and 1.7 for persistent tobacco use. Although there was
insufficient power to exclude coincident linkage (p =
0.26), complete pleiotropy could be excluded (p = 0.02).
Discussion
A variety of genetically influenced characteristics most
likely contribute to the increased risk for tobacco usage
seen in Mission Indians. A number of psychosocial varia-
bles have been associated with tobacco usage in Native
Americans teens including life events and availability [9-
11]. However, this is the first study to determine heritabil-
ity of tobacco usage and to conduct a linkage analysis to
tobacco related phenotypes in Native Americans. Regular
and persistent tobacco use were both found to be moder-
ately heritable as measured by h2. Additionally, several
chromosomal loci were identified as regions of interest
that may harbor tobacco usage genes.
There were two loci identified on chromosome 1, one for
persistent tobacco usage at 75 cM, and one for regular
tobacco usage at 175 cM. Both of these loci were identified
in a genome scan conducted using the Collaborative
Study of the Genetics of Alcoholism (COGA) dataset for
habitual smoking and alcohol dependence [19]. Loci on
chromosome 1 have been identified previously for alco-
hol dependence phenotypes in a number of studies [55-
60]. However, using the COGA dataset, Bierut [23] dem-
onstrated the combined phenotype of alcohol depend-
ence and habitual smoking had allele sharing among
sibling pairs that was similar to results for alcohol
dependence alone. Additionally, no evidence for linkage
to alcohol dependence has been found at that location on
chromosome 1 in this Mission Indian population [31].
Taken together these results suggest that there may be spe-
cific genetic factors impacting tobacco usage that do not
impact alcohol dependence within this support interval
on chromosome 1.
One of the most consistent findings between several
genetic linkage studies conducted in Native American and
other mixed heritage populations is evidence for a protec-
tive association for alcohol dependence and related
behaviors in a region on chromosome 4 near the Alcohol
dehydrogenase gene cluster. In a genetic linkage study
evaluating large families who were members of a South-
west Indian tribe, three loci in this region on chromosome
4q showed evidence for linkage [61]. Evidence for linkage
at this site, in Mission Indians, was also identified in a
genome scan for a severity of alcohol drinking phenotype
[31]. A protective association has also been found
between polymorphisms in ADH1B3, alcohol depend-
ence, and tobacco usage in this population [34]. Addition-
ally both the "unaffected by alcoholism" [55] and
"maximum drinks ever consumed in a 24 hour period"
[62], phenotypes, were found to give evidence for linkage
on chromosome 4 in the region of the ADH gene cluster
in the COGA study. Evidence for linkage to tobacco
dependence at this same general region of the genome on
chromosome 4 has also been demonstrated in both the
Richmond and Christchurch samples described in the
publications by Straub [22], and by Duggirala [63]. The
linkage analysis for persistent tobacco use in Mission Indi-
ans also supports these observations. The detection of a
Multipoint, univariate and bivariate analysis for chromosome  4 Figure 3
Multipoint, univariate and bivariate analysis for chromosome 
4. Univariate analysis of the "persistent tobacco use" pheno-
type is shown in the heavy dark line and univariate analysis 
for the "drinking severity" phenotype in the thin line. The 
bivariate analysis of the "persistent tobacco usage and drink-
ing severity" is shown in the dark line. The analysis assumes a 
latent normally distributed variable with a threshold above 
which an individual is affected. The maximum LOD score for 
the bivariate analysis for the region is 3.4 compared to a 
maximum of 2.8 for drinking severity score and 1.7 for per-
sistent tobacco use. Although there was insufficient power to 
exclude coincident linkage (p = 0.26), complete pleiotropy 
could be excluded (p = 0.02).BMC Medical Genetics 2006, 7:9 http://www.biomedcentral.com/1471-2350/7/9
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linkage signal for drinking severity using the same cohort
in this same region suggests that there may be a sequence
variant that affects substance abuse in general or that there
are at least two tightly linked variants that affect different
aspects of substance abuse behavior. The bivariate analy-
sis done in these studies is not sufficiently powered to dis-
tinguish between these possibilities.
There is one additional locus of interest in this Mission
Indian study that was also identified in previous linkage
analyses for alcohol-related phenotypes. Evidence for
linkage was found on chromosome 6 for the regular
tobacco use phenotype in a support interval previously
identified for an alcohol withdrawal severity phenotype in
this Mission Indian population [31]. Additionally, evi-
dence for an epidemiological measure of smoking was
also found at this site using the COGA dataset [64].
Additional loci of interest were found on chromosome 7,
13 and 22 for regular smoking that have been identified
in other studies [19,25]. Only a few findings appear to be
replicated between studies. This is most likely related to a
number of factors. Some of the studies utilized partici-
pants recruited from clinical populations enriched for
psychiatric disorders whereas some were population
based samples using mixed ethnicities. Also, differing def-
initions of smoking and tobacco dependence were used.
More replications and additional studies in different eth-
nic groups are needed to further evaluate the linkage
results [24].
The results of this study should be interpreted in the con-
text of several limitations. First, the findings may not gen-
eralize to other Native Americans or represent all Mission
Indians. Second, comparisons of linkage findings to non-
Indian populations of drug abusers may be limited by dif-
ferences in a host of potential genetic and environmental
variables. Third, the underlying assumption that these
phenotypes are normally distributed, an assumption of
variance component analyses, may not be warranted.
Finally, because this population has significant admixture
estimates of allele frequencies may produce biased LOD
scores. The linkage analyses do not give us any informa-
tion on whether the genes within the loci identified are
coding for protective or risk factors. Despite these limita-
tions, this report represents an important first step in an
ongoing investigation to understand the genetic determi-
nants associated with the development of substance use
disorders in this high risk and understudied ethnic group.
Conclusion
These data represent the first family-based genome-wide
chromosome segregation analyses for tobacco use pheno-
types in Native Americans. The results corroborated the
possible importance of several chromosomal regions
highlighted in prior linkage studies for substance abuse
phenotypes and identify new regions of the genome for
this ethnic group and/or Mission Indians. A replicate
study is underway to test the reliability of the findings.
Additionally, these data lend support for the hypothesis
that cigarette smoking, alcohol dependence and other
consumptive behaviors may share some common risk
and/or protective factors in this Mission Indian popula-
tion.
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